Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Base estimates & calculations
1.3 Forecast parameters
1.4 COVID-19 impact analysis at global level
1.5 Data validation
1.6 Data Sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Immunoglobulin industry 3600 synopsis, 2018 – 2032
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Product type trends
2.1.4 Route of administration trends
2.1.5 Application trends
2.1.6 End-use trends
Chapter 3 Immunoglobulin Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing geriatric population
3.2.1.2 Increasing prevalence of immunodeficiency diseases
3.2.1.3 Growing adoption of immunoglobulin
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of therapy
3.2.2.2 Stringent government regulations
3.3 Growth potential analysis
3.3.1 By product type
3.3.2 By route of administration
3.3.3 By application
3.3.4 By end-use
3.4 COVID- 19 impact analysis
3.5 Route of administration comparison table
3.6 Regulatory landscape
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Immunoglobulin Market Size and Forecast, By Product Type (USD Million)
5.1 Key trends, by product type
5.2 IgG
5.3 IgA
5.4 IgM
5.5 IgD
5.6 IgE
Chapter 6 Immunoglobulin Market Size and Forecast, By Route of Administration (USD Million)
6.1 Key trends, by route of administration
6.2 Intravenous (IVIG)
6.3 Subcutaneous (SCIg)
Chapter 7 Immunoglobulin Market Size and Forecast, By Application (USD Million)
7.1 Key trends, by application
7.2 Chronic inflammatory demyelinating polyneuropathy (CIDP)
7.3 Multifocal motor neuropathy (MMN)
7.4 Primary immunodeficiency disease (PID)
7.5 Secondary immunodeficiency disease (SID)
7.6 Guillain-Barre syndrome
7.7 Immune thrombocytopenic purpura (ITP)
7.8 Other applications
Chapter 8 Immunoglobulin Market Size and Forecast, By End-use (USD Million)
8.1 Key trends, by end-use
8.2 Hospitals
8.3 Clinics
8.4 Homecare
Chapter 9 Immunoglobulin Market Size and Forecast, By Region (USD Million)
9.1 Key trends, by region
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Poland
9.3.7 Switzerland
9.3.8 Netherlands
9.3.9 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Thailand
9.4.7 Indonesia
9.4.8 Vietnam
9.4.9 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Columbia
9.5.5 Chile
9.5.6 Peru
9.5.7 Rest of Latin America
9.6 MEA
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Israel
9.6.5 Rest of MEA
Chapter 10 Company Profiles
10.1 Baxter international Inc.
10.2 Johnson & Johnson (Omrix Biopharmaceuticals Inc.)
10.3 Pfizer Inc.
10.4 Takeda Pharmaceutical Company Limited
10.5 Grifols SA
10.6 Kedrion S.p.A
10.7 CSL Behring
10.8 Biotest AG
10.9 Octapharma AG
10.10 ADMA Biologics, Inc.
10.11 Shanghai RAAS Blood Products Co. Ltd
